JECHO Launches New Project Against COVID-19

A new pharmaceutical research called “Preparation and preclinical study of anti-novel coronavirus therapeutic monoclonal antibody” is now approved by government authority where JECHO located in, after expert review.

This is the critical and new research project under current situation all over the world with pressing needs. As the only one enterprise researching and developing therapeutic antibody against Coronavirus (COVID-19) within Tianjin-Singapore Eco City, JECHO is now working closely with academy, research institute and hospital for developing the most effective and innovative biological medicines.

JECHO strives to make contribution to human health, saving people’s lives and determined to be a leader of biopharmaceutical industry in China.


Project introduction from Jecho Laboratories Inc. at


Reference : Public infomation local government released *

* Note: Only Chinese version available

© Jecho Biopharmaceuticals 2019-2021

2633 Zhongbin Avenue, China-Singapore Tianjin Eco-City, Binhai New Area, Tianjin 300467, P.R.C.